Magnetic fluid hyperthermia therapy for malignant brain tumors-an ethical discussion

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 4, 2009, Pages 387-393

  Müller, Sabine ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Brain tumor; Glioblastoma multiforme; Magnetic fluid hyperthermia; Nano Cancer therapy; Nanoethics; Nanotherapy

Indexed keywords

BRAIN TUMORS; CANCER THERAPY; FURTHER DEVELOPMENT; GLIOBLASTOMA MULTIFORME; MAGNETIC FLUID HYPERTHERMIA; PHASE II; SIDE EFFECT;

MAGNETIC FLUIDS; NANOPARTICLES; ONCOLOGY; TUMORS;

HYPERTHERMIA THERAPY;

BENEFICENCE; BRAIN TUMOR; CANCER THERAPY; HUMAN; HYPERTHERMIC THERAPY; JUSTICE; MEDICAL ETHICS; NANOTECHNOLOGY; REVIEW; TREATMENT RESPONSE;

BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; FLUID THERAPY; HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS;

EID: 70949083250     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.01.011     Document Type: Review

References (39)

1. Ohgaki H., and Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64 (2005) 479-489
2. Maier-Hauff K., Rothe R., Scholz R., Gneveckow U., Wust P., Thiesen B., et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81 (2007) 53-60
3. Jordan A., Scholz R., Maier-Hauff K., Van Landeghem F.K.H., Waldoefner N., Teichgraeber U., et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78 (2005) 7-14
4. American Brain Tumor Association (ABTA). A primer of brain tumors. Massachusetts General Hospital Neurological Service. Available from: (2005). http://neurosurgery.mgh.harvard.edu/abta/primer.htm
5. Merkel R., Boer G., Fegert J., and Galert T. Intervening in the brain. Changing psyche and society (2007), Springer Verlag, Berlin, Heidelberg
6. Müller S. Minimal-invasive und nanoskalige Therapien von Gehirnerkrankungen-Eine medizinethische Diskussion. In: Nordmann A., Schummer J., and Schwarz A. (Eds). Nanotechnologien im Kontext (2006), Akademische Verlagsgesellschaft, Berlin 345-370
7. Müller S. Dilemmata bei operativen Eingriffen in das Gehirn. In: Groß D., and Müller S. (Eds). Sind die Gedanken frei? (2007), Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin 229-268
8. Loh A., Simon D., Kriston L., and Härter M. Shared decision-making in medicine [review]. Dtsch Ärztebl 104 (2007) A1483-A1488
9. Scheibler F. Shared decision making (2004), Verlag Hans Huber, Bern
10. Beauchamp T.L., and Childress J.F. Principles of biomedical ethics. 5th ed. (2001), Oxford University Press, Oxford
11. Jordan A. Size matters. How the tiny world of nanotechnology is having a big impact on the pharma industry. Next Generation Pharma (2007). http://www.ngpharma.com/article/Issue-4/Drug-Discovery-AND-Development/S ize-matters/ Available from:
12. cc-NanoChem e. V. First cancer patients successfully treated using nanotherapy. Available from: (2004). http://obsolet.cc-nanochem.de/1-media.php
13. SmallTimes. Nanoparticles fight cancer cells with lethally high 'fever'. Available from: (2009). http://www.smalltimes.com/articles/stm_print_screen.cfm?article_id=26896 7
14. Gneveckow U., Jordan A., Scholz R., Brüß V., Waldöfner N., Ricke J., et al. Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys 31 (2004) 1444-1451
15. Jordan A., Scholz R., Maier-Hauff K., Johannsen M., Wust P., Nadobny J., et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumours with magnetic fluid hyperthermia. J Magn Magn Mater 225 (2001) 118-126
16. Jordan A. Thermotherapy using magnetic nanoparticles: principles and clinical application of nanotherapy. EuroNanoForum Proc (2005) 76-80
17. Wust P., Gneveckow U., Johannsen M., Böhmer D., Henkel T., Kahmann F., et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22 (2006) 673-685
18. Jordan A., Scholz R., Wust P., Fähling H., and Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201 (1999) 413-419
19. Jordan A., Wust P., Fahling H., John W., Hinz A., and Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 9 (1993) 51-68
20. Jordan A., Wust P., Scholz R., Tesche B., Fähling H., Mitrovics T., et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 12 (1996) 705-722
21. Jordan A., Scholz R., Wust P., Fähling H., Krause J., Wlodarczyk W., et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 13 (1997) 587-605
22. Johannsen M., Thiesen B., Gneveckow U., Taymoorian K., Waldöfner N., Scholz R., et al. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic Dunning rat model of prostate cancer. Prostate 66 (2006) 97-104
23. ETC Group [homepage on the Internet]. Available from:. http://www.etcgroup.org/en
24. ETC Group. Nanotech Rx. Medical applications of nano-scale technologies: what impact on marginalized communities?. Available from: (2006). http://www.etcgroup.org/en/materials/publications.html?pub_id=593
25. Center for Responsible Nanotechnology [homepage on the Internet]. Available from:. http://www.crnano.org
26. AAP. Call for moratorium on nanotechnology. Available from: (2007). http://news.ninemsn.com.au/article.aspx?id=255207
27. Arnall A.H. Future technologies, today's choices. A report for the Greenpeace Environmental Trust (2003), London. http://www.greenpeace.org.uk Available from:
28. Nordmann A. If and then: a critique of speculative nanoethics. Nanoethics 1 (2007) 31-46
29. Resnik D.B., and Tinkle S.S. Ethics in nanomedicine. Nanomedicine 2 (2007) 345-350
30. Grunwald A. Nanotechnology-a new field of ethical inquiry?. Sci Eng Ethics 11 (2005) 187-201
31. Ebbesen M., Andersen S., and Besenbacher F. Ethics in nanotechnology: starting from scratch?. Bull Sci Technol Soc 26 (2006) 451-462
32. Sharma H.S. Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomedicine 2 (2007) 753-758
33. Unfried K., Albrecht C., Klotz L.O., Mikecz Av., Grether-Beck S., and Schins R.P.F. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1-20 (2007)
34. Swiss Reinsurance Company. Nanotechnologie. Kleine Teile-grosse Zukunft (2004), Zürich, Switzerland. http://www.swissre.com/resources/48c84780455c7a06b0d0ba80a45d76a0-Publ04_Nanotech_de.pdf Available from:
35. Kurschat R. Flüssigkeiten mit magnetischen Eigenschaften. Anwendung von Ferrofluiden in Technik und Medizin (2005), Zurich, Switzerland Neue Zürcher Zeitung
36. Linkov I., Satterstrom F.K., and Corey L.M. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 4 (2008) 167-171
37. Lee S.B. Focus on nanoparticles for cancer diagnosis and therapeutics. Nanomedicine 2 (2007) 647-648
38. Shrader-Frechette K. Nanotoxicology and ethical considerations for informed consent. Nanoethics 1 (2007) 47-56
39. Mnyusiwalla A., Daar A.S., and Singer P.A. "Mind the gap": science and ethics in nanotechnology. Nanotechnology 14 (2003) R9-R13